Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
8.91
-0.17 (-1.87%)
Dec 20, 2024, 4:00 PM EST - Market closed
Avalo Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$33.00
Upside
+270.37%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +348.93% | Dec 19, 2024 |
| LUCID CAPITAL MARKETS | LUCID CAPITAL MARKETS | Strong Buy Initiates $24 | Strong Buy | Initiates | $24 | +169.36% | Dec 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 24, 2024 |
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $35 | Hold → Buy | Upgrades | $35 | +292.82% | Apr 16, 2024 |
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jun 27, 2023 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $2,160 → $180 | Buy → Hold | Downgrades | $2,160 → $180 | +1,920.20% | Jun 27, 2023 |
| RBC Capital | RBC Capital | Buy Maintains $4,080 → $2,160 | Buy | Maintains | $4,080 → $2,160 | +24,142.42% | May 10, 2023 |
| Jefferies | Jefferies | Hold → Sell Downgrades $720 | Hold → Sell | Downgrades | $720 | +7,980.81% | Feb 8, 2023 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $14,400 → $2,160 | Strong Buy → Hold | Downgrades | $14,400 → $2,160 | +24,142.42% | Mar 3, 2022 |
| RBC Capital | RBC Capital | Buy Maintains $14,400 → $11,520 | Buy | Maintains | $14,400 → $11,520 | +129,192.93% | Mar 3, 2022 |
| RBC Capital | RBC Capital | Buy Initiates $17,280 | Buy | Initiates | $17,280 | +193,839.39% | Sep 24, 2021 |